Slovenia's Krka revises up 2019 profit, says virus impact unpredictable

Krka dd Novo Mesto

19/03/2020 07:43

LJUBLJANA, March 19 (Reuters) - Slovenia's pharmaceutical
producer Krka  KRKG.LJ  revised up its preliminary group net
profit to 244.3 million euros ($266.41 million) for 2019 on
Friday, following an estimate released in January showing a
profit of 242 million euros. 
    It said the profit was 40% higher than in 2018, with sales
amounting to 1.49 billion euros.  urn:newsml:reuters.com:*:nL8N29Z3Z2
    The company said its operations had not been hit by the
coronavirus epidemic so far but said it was difficult to
forecast what its impact on the firm would be as consequences of
the spreading virus were "fast and unpredictable".
    Slovenia has so far confirmed 286 cases of coronavirus, one
person has died.

    ($1 = 0.9170 euros)

 (Reporting by Marja Novak; Editing by Edmund Blair)
 ((Marja.Novak@thomsonreuters.com; +386-1-5058805, Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))